3rd Quarter 2022 Results (Separate)

RNS Number : 2910F
Commercial Intnl Bank (Egypt) SAE
04 November 2022
 

Text Box: Internal














 


















 











Commercial International Bank (Egypt) S.A.E.

Condensed Separate Financial Statements

September 30, 2022

Click on, or paste the following link into your web browser, to view the associated PDF document

http://www.rns-pdf.londonstockexchange.com/rns/2910F_1-2022-11-3.pdf















 









 





Condensed Separate Interim Statement of Financial Position as at
 September 30, 2022

 

 

Notes

Sep. 30, 2022

 

Dec. 31, 2021

 


EGP Thousands

 

EGP Thousands

 


 

 

 

 


 


Assets

 

 

 


 


Cash and balances at the central bank

8

43,776,754

 

43,385,222

 


Due from  banks

9

90,378,194

 

79,991,287

 


Loans and advances to banks, net

11

1,944,633

 

312,216

 


Loans and advances to customers, net

12

176,669,649

 

144,765,808

 


Derivative financial instruments

 

951,214

 

225,376

 


Investments


 

 


 


- Financial Assets at Fair Value through P&L

13

-

 

240,987

 


- Financial Assets at Fair Value through OCI

13

230,060,807

 

192,390,931

 


- Financial Assets at Amortized cost

13

32,306,835

 

20,318,767

 


- Investments in associates and subsidiaries

14

1,074,250

 

1,014,350

 


Other assets

15

10,167,659

 

11,141,917

 


Deferred tax assets (Liabilities)

 

727,276

 

460,026

 


Property and equipment

16

2,302,530

 

2,404,237

 


Total assets

 

590,359,801

 

496,651,124

 


Liabilities and equity


 

 


 


Liabilities


 

 


 


Due to banks

17

1,703,884

 

862,759

 


Due to customers

18

497,584,590

 

406,100,916

 


Derivative financial instruments

 

43,987

 

265,265

 


Current income tax liabilities


2,678,372

 

2,234,985

 


Other liabilities

19

9,945,543

 

8,021,310

 


Issued debt instruments

20

1,940,240

 

1,557,263

 


Other loans

 

6,257,126

 

5,140,782

 


Other Provisions

21

5,675,006

 

3,539,676

 


Total liabilities

 

525,828,748

 

427,722,956

 


Equity

 

 

 


 


Issued and paid up capital

26

29,825,134

 

19,702,418

 


Reserves


20,381,196

 

33,767,423

 


Reserve for employee stock ownership plan (ESOP)

 

1,751,123

 

1,674,392

 


Retained earnings *

 

12,573,600

 

13,783,935

 


Total equity and net profit for the period / year

 

64,531,053

 

68,928,168

 


Total liabilities and equity

 

590,359,801

 

496,651,124

 




 

 


 



 




 

 

 

 


 


 


 



 







 


The accompanying notes are an integral part of these financial statements.

 




 

 

(Review report attached)

 




 


*Including net profit for the current period

 




 



 







 



 



 


Hussein Abaza

Sherif Samy

 

CEO & Managing Director


Chairman


 



 

 

 




 

 



 

 

 

 


 



Condensed Separate Interim Income Statement for the period ended September 30, 2022

 

 

 




 

 

 


Last 9 Months


Last 9 Months

 



 


Notes

 

Sep. 30, 2022

 


Sep. 30, 2021

 

 




EGP Thousands

 


EGP Thousands

 

 




 

 



 

 

Interest and similar income



38,761,627

 


32,568,923


 

Interest and similar expense



(17,050,977)

 


(14,463,322)


 

Net interest income



21,710,650

 


18,105,601


 

 



 

 




 

Fee and commission income



3,900,488

 


2,895,435


 

Fee and commission expense



(1,730,066)

 


(1,129,866)


 

Net fee and commission income



2,170,422

 


1,765,569


 

 



 

 




 

Dividends income

 


64,372

 


82,426


 

Net trading income

5

 

1,431,729

 


484,774


 

Profits (Losses) on financial investments

13

 

1,096,850

 


634,108


 

Administrative expenses

 


(5,024,897)

 


(4,382,463)


 

Other operating (expenses) income

6


(3,399,057)

 


(1,366,178)


 

Impairment release (charges) for credit losses

 

 

(262,606)

 


(1,325,770)


 

Profit before income tax


 

17,787,463

 


13,998,067


 

 



 

 




 

Income tax expense

25


(4,984,283)

 


(4,115,227)


 

Deferred tax assets (Liabilities)

25


(597,258)

 


11,845


 

Net profit for the period

 


12,205,922

 


9,894,685


 

 



 

 




 

Earning per share

7


 

 




 

Basic



3.62

 


2.97


 

Diluted



3.60

 


2.95


 




 

 




 


 


 

 




 

 

 

 

 

 




 

 

 

 


 

 








 

 





















































 

Hussein Abaza






CEO & Managing Director

 




Sherif Samy

 








Chairman


 



 

 


 






 





Condensed Separate Interim Statement of Comprehensive Income for the period ended September 30, 2022

 

 



 

 



 




Last 9 Months

 


Last 9 Months


 




Sep. 30, 2022

 


Sep. 30, 2021


 




EGP Thousands

 


EGP Thousands


 

 

 


 

 




 

Net profit for the period



12,205,922

 


9,894,685


 




 

 




 

Change in fair value of financial instruments measured at fair value through other comprehensive income after income tax



(13,128,801)

 


(2,374,495)


 

Transferred to RE from financial assets at fair value through OCI



(4,128)

 


(177,362)


 

Effect of ECL in fair value of debt instruments measured at fair value through OCI



233,717

 


(98,246)


 

Total comprehensive income for the period



(693,290)

 


7,244,582


 

 

 


 

 




 

 



 





 




 





 




 





 




 





 

 



 





 

 



 





 

 



 

 




 




 

 




 

 

 


 

 




 

 





Condensed Separate Interim Cash Flows for the period ended September 30, 2022

 

 


 





 





 

 

 







 

Notes

Sep. 30, 2022

 

Sep. 30, 2021




EGP Thousands

 

EGP Thousands




 

 


Cash flow from operating activities



 

 


Profit before income tax



17,787,463

 

13,998,067

Adjustments to reconcile profits to net cash provided by operating  activities



 

 


Fixed assets depreciation

 

16

654,220

 

636,413

Impairment charge for credit losses (Loans and advances to customers and banks)

 

 

(16,255)

 

1,385,835

Other provisions charges

 

21

1,803,863

 

190,858

Impairment charge for credit losses (due from banks)

 

 

849

 

38,181

Impairment (Released) charge for credit losses (financial investments)



278,012

 

(98,246)

Impairment (Released) charge for other assets



(277,768)

 

31,975

Exchange revaluation differences for financial assets at fair value through OCI and AC



(3,745,045)

 

40,050

Utilization of other provisions


21

(1,857)

 

(44,978)

Other provisions no longer used

 

21

(101)

 

(12,255)

Exchange differences of other provisions

 

21

333,425

 

(13,722)

Losses (profits) from selling property and equipment

 

 

(2,192)

 

(2,124)

Losses (profits) from selling financial investments at fair value through OCI

 

13

(1,096,850)

 

(643,467)

Shares based payments

 

 

579,653

 

477,644

Impairment (Released) charges of investments in associates

 

 

-

 

9,359

Operating profits before changes in operating assets and liabilities



16,297,417

 

15,993,590

 



 

 


Net decrease (increase) in assets and  liabilities



 

 


Due from banks



845,633

 

(272,238)

Financial assets at fair value through P&L


13

240,987

 

153,260

Derivative financial instruments

 

 

(947,116)

 

(24,448)

Loans and advances to banks and customers

 

11 - 12

(33,520,003)

 

(20,847,787)

Other assets

 

 

1,242,254

 

(1,631,518)

Due to banks

 

17

841,125

 

(7,272,811)

Due to customers

 

18

91,483,674

 

62,999,029

Current income tax obligations paid

 

 

(2,305,911)

 

(2,152,739)

Other liabilities

 

 

(310,752)

 

1,414,946

Net cash used in (generated from) operating activities

 

 

73,867,308

 

48,359,284

 

 

 

 

 


Cash flow from investing activities



 

 


Payments for investment in subsidiaries and associates.



(59,900)

 

(158,360)

Payment for purchases of property, equipment and branches  constructions



(542,743)

 

(669,801)

Proceeds from selling property and equipment



2,192

 

2,124

Proceeds from redemption of financial assets at amortized cost



6,569,803

 

4,725,376

Payment for purchases of financial assets at amortized cost



(18,239,332)

 

(3,844)

Payment for purchases of financial assets at fair value through OCI



(114,918,927)

 

(207,918,546)

Proceeds from selling financial assets at fair value through OCI



73,463,225

 

146,303,855

Net cash generated from (used in) investing activities



(53,725,682)

 

(57,719,196)

 



 

 


 



 

 





 

 


 

 

 

 

 





 

 


 



 

 
















 

Condensed Separate Interim Cash Flows for the period ended September 30, 2022 (Cont.)

 

 








Sep. 30, 2022

 

Sep. 30, 2021

 



EGP Thousands

 

EGP Thousands

 



 

 


 

Cash flow from financing activities


 

 


 

Other loans


1,116,344

 

(2,113,845)

 

Dividends paid


(4,410,322)

 

(1,360,652)

 

Issued debt instruments


382,977

 

1,556,032

 

Capital increase


122,716

 

-

 

Net cash generated from (used in) financing activities


(2,788,285)

 

(1,918,465)

 

 


 

 


 



 

 


 

Net (decrease) increase in cash and cash equivalent during the period


17,353,341

 

(11,278,377)

 

Beginning balance of cash and cash equivalent


60,891,899

 

75,965,247

 

Cash and cash equivalent at the end of the period


78,245,240

 

64,686,870

 

 


 

 


 

Cash and cash equivalent comprise:


 

 


 

Cash and balances at the central bank


43,776,754

 

33,207,606

 

Due from banks


90,419,482

 

72,015,406

 

Treasury bills and other governmental  notes

10

87,119,766

 

65,654,913

 

Obligatory reserve balance with CBE

 

(38,022,832)

 

(27,183,002)

 

Due from banks with maturities more than three months


(22,949,758)

 

(16,980,376)

 

Treasury bills with maturity more than three months


(82,098,172)

 

(62,027,677)

 

Total cash and cash equivalent


78,245,240

 

64,686,870

 

'

 

 

 

 

 
















 

Condensed Separate Interim statement of  changes in shareholders' equity  for the period ended September 30, 2021

 

 




Sep. 30, 2021

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total
















EGP Thousands






Beginning balance

14,776,813

2,778,135

24,765,658

1,549,445

14,906

3,970,987

6,423

10,477,611

1,064,648

59,404,626






Capital increase

4,925,605

-

(4,925,605)

-

-

-

-

-

-

-






Transferred to reserves

-

514,939

8,420,479

-

1,094

-

-

(8,936,512)

-

-





Dividend paid

-

-

-

-

-

-

-

(1,360,652)

-

(1,360,652)






Net profit of the period

-

-

-

-

-

-

-

9,894,685

-

9,894,685






Transferred from reserve of financial assets at fair value through OCI

-

-

-

-

-

(177,362)

-

177,362

-

-






Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

8,333

-

8,333






Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(2,374,495)

-

-

-

(2,374,495)






Transferred (from) to bank risk reserve

-

-

-

-

-

-

2,718

(2,718)

-

-






Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

(98,246)

-

-

-

(98,246)






Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

477,644

477,644






Ending balance

19,702,418

3,293,074

28,260,532

1,549,445

16,000

1,320,884

9,141

10,258,109

1,542,292

65,951,895






















































































Condensed Separate Interim statement of  changes in shareholders' equity for the period ended September 30, 2022

 

 




 

 




Sep. 30, 2022

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 


 










EGP Thousands

 





Beginning balance

19,702,418

3,293,074

28,260,532

1,549,445

16,000

639,231

9,141

13,783,935

1,674,392

68,928,168

 

 

 

 


Capital increase

10,122,716

-

(10,000,000)

-

-

-

-

-

-

122,716

 

 

 

 


Transferred to reserves

-

670,872

8,836,326

-

2,947

-

-

(9,007,223)

(502,922)

-

 

 

 

 

Dividend paid

-

-

-

-

-

-

-

(4,410,322)

-

(4,410,322)

 

 

 

 

Net profit of the period

-

-

-

-

-

-

-

12,205,922

-

12,205,922

 

 

 

 


Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

(4,128)

-

4,128

-

-

 

 

 

 


Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

-

-

-

 

 

 

 


Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(13,128,801)

-

-

-

(13,128,801)

 

 

 

 


Transferred (from) to banking risk reserve

-

-

-

-

-

-

2,840

(2,840)

-

-

 

 

 

 


Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

233,717

-

-

-

233,717

 

 

 

 


Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

579,653

579,653

 

 

 

 


Ending balance

29,825,134

3,963,946

27,096,858

1,549,445

18,947

(12,259,981)

11,981

12,573,600

1,751,123

64,531,053

 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 














 


















 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTFLFSALELVIIF
UK 100

Latest directors dealings